Showing results (121-130 of 149) with videos related to
Sort By:
Pageof 15
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 6, 2005
Rosiglitazone protects against cyclosporine-induced pancreatic and renal injury in ratsByung Ha Chung, Can Li, Bo Kyung Sun, et al.Journal of Cellular Biochemistry|April 20, 2005
Proteomic analysis of differential protein expression in response to epidermal growth factor in neonatal porcine pancreatic cell monolayersOak-Kee Hong, Sun-Hee Suh, Hyuk-Sang Kwon, et al.Children (Basel, Switzerland)|July 27, 2022
A Comparison of Emergency Department Revisit Rates of Pediatric Patients between Pre-COVID-19 and COVID-19 PeriodsMyeong Namgung, Dong Hoon Lee, Sung Jin Bae, et al.Plos Biology|September 14, 2023
A safety mechanism enables tissue-specific resistance to protein aggregation during aging in C. elegansRaimund Jung, Marie C Lechler, Ana Fernandez-Villegas, et al.Investigational New Drugs|June 24, 2009
Yttrium-90-ibritumomab tiuxetan in combination with intravenous busulfan, cyclophosphamide, and etoposide followed by autologous stem cell transplantation in patients with relapsed or refractory B-cell non-Hodgkin's lymphomaByung Woog Kang, Won Seog Kim, Chul Kim, et al.Emergency Medicine Journal : EMJ|April 21, 2012
Current practices for paediatric procedural sedation and analgesia in emergency departments: results of a nationwide survey in KoreaJun Seok Seo, Do Kyun Kim, Youngjoon Kang, et al.Cancer Chemotherapy and Pharmacology|August 8, 2013
A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinomaInkeun Park, Min-Hee Ryu, Yoon Hee Choi, et al.Cytotherapy|August 21, 2012
Tonsil-derived mesenchymal stromal cells: evaluation of biologic, immunologic and genetic factors for successful bankingKyung-Ha Ryu, Kyung-Ah Cho, Hae Sang Park, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2021
Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic CarcinomaEun Joo Kang, Myung-Ju Ahn, Chan-Young Ock, et al.Cancer Chemotherapy and Pharmacology|November 22, 2015
A phase II trial of modified FOLFOX6 as first-line therapy for adenocarcinoma of an unknown primary siteDong-Yeop Shin, Yoon Hee Choi, Hyo-Rak Lee, et al.Pageof 15